{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:05:11Z","timestamp":1761599111539},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T00:00:00Z","timestamp":1344816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> Brain metastasis from ovarian cancer is a very rare phenomenon. <jats:italic>BRCA1<\/jats:italic>\u2010related ovarian cancers show specific pathobiological profiles, advanced stage, and sensitivity to chemotherapeutic agents. However, no clear relationship to any known metastatic behavior has yet been found, so we examined the <jats:italic>BRCA1<\/jats:italic> mutation and expression profiles in ovarian cancer cases with brain metastases.<\/jats:p><jats:p><jats:bold>Material and Methods:\u2002<\/jats:bold> We examined our clinical records of 340 ovarian cancer cases from 1983 to 2007 to ascertain cases with brain metastases. In the molecular genetic analyses, we performed loss of heterozygosity (LOH), direct sequence and immunohistochemical staining analysis of <jats:italic>BRCA1<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> We ascertained seven cases with brain metastases in 340 ovarian cancer cases (7\/340\u2003=\u20032.1%). Among the seven cases, three cases had ovarian and\/or breast cancer patients in third\u2010degree relatives. We detected four LOH\u2010positive cases and a germline mutation of <jats:italic>BRCA1<\/jats:italic> in two of the four cases. Furthermore, the remaining two cases showed absent staining of the <jats:italic>BRCA1<\/jats:italic> protein. Therefore, four of seven cases with brain metastases were considered <jats:italic>BRCA1<\/jats:italic>\u2010related ovarian cancers (4\/7\u2003=\u200357.1%). All four of the cases were serous adenocarcinoma.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Our results suggest that the loss of <jats:italic>BRCA1<\/jats:italic> function may be involved in the phenomenon of brain metastasis from ovarian cancer. Further molecular biologic analyses will be required for a better understanding of this rare phenomenon.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2012.01961.x","type":"journal-article","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T01:46:32Z","timestamp":1344908792000},"page":"292-296","source":"Crossref","is-referenced-by-count":28,"title":["Increased incidence of brain metastases in <i>BRCA1<\/i>\u2010related ovarian cancers"],"prefix":"10.1111","volume":"39","author":[{"given":"Masayuki","family":"Sekine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Komata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Haino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,13]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.05.026"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1082"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90515-5"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059246"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6085"},{"key":"e_1_2_7_8_2","first-page":"3144","article-title":"Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population","volume":"7","author":"Sekine M","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2000.tb00959.x"},{"key":"e_1_2_7_10_2","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1\u2010mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton DF","year":"1995","journal-title":"Am J Hum Genet"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.17.2260"},{"key":"e_1_2_7_13_2","first-page":"235","article-title":"Clinical features of ovarian cancer in Japanese women with germ\u2010line mutations of BRCA1","volume":"4","author":"Aida H","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2005.00143.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920215)69:4<972::AID-CNCR2820690423>3.0.CO;2-P"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl010"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00615-3"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/em.10069"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(01)02451-9"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.028084"},{"key":"e_1_2_7_21_2","first-page":"1825","article-title":"Expression of metastasis\u2010related nm23\u2010H1 and nm23\u2010H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGFR, c\u2010erbB\u20102, and c\u2010erbB\u20103 genes, and sex steroid receptor expression","volume":"54","author":"Mandai M","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_7_22_2","first-page":"1003","article-title":"Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation","volume":"29","author":"Qiu L","year":"2007","journal-title":"Int J Oncol"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2012.01961.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2012.01961.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:53:21Z","timestamp":1697334801000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2012.01961.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1447-0756.2012.01961.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2012.01961.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,13]]}}}